Mark Hughes Foundation 2020 Innovation Grant Round - Closes 5pm Monday 14 September 2020
After a successful 2020 Beanies for Brain Cancer Round, the MHF Scientific Committee is once again inviting researchers across Australia to work together, collaborate and put forward innovative research projects to improve outcomes for patients diagnosed with brain cancer. The MHF Scientific Committee will consider all submissions but are looking particularly for projects that bring new ideas and people together to collaborate.
Up to $1.5 million is being offered with between $150,000 – $200,000 available per two-year project.
It is open to health and medical researchers employed by an Australian organisation, including universities, research institutes, hospitals and health districts. Funding outcomes will be announced before the end of 2020.
Grants will be allocated via an open and competitive process managed by Hunter Medical Research Institute’s (HMRI’s) Research Services Team. The MHF Scientific Committee will be selecting projects on merit that are innovative and align with MHF core objectives - to promote research most likely to improve the outcomes of patients with brain cancer in Australia.
Please direct any enquiries regarding the grants round to firstname.lastname@example.org.
Supporting MHF Grant Round Applications
Mark Hughes Foundation Preclinical Pipeline for Advancing Cancer Therapeutics
The Mark Hughes Foundation Preclinical Pipeline for Advancing Cancer Therapeutics (MHF PACT) has been established to improve the progress of novel oncology drugs into preclinical efficacy studies. We have expertise in subcutaneous and orthotopic cancer inductions of both immunocompetent and immunocompromised models.
If your MHF research innovation grant application investigates novel oncology drugs and you are considering progressing to in vivo experiments, then please contact the PACT team (email@example.com) to help you design and budget for your in vivo experiments.
We will discuss relevant models, design best practice experiments including combination with chemotherapy and radiotherapy (using the only SARRP in Australia) and prepare a budget for submission with your grant application.
If you are successful, we will then work with you to deliver the experiments including approvals submissions (ethics, biosafety and radiation), pilot studies, full drug treatment experiments and preparing samples for further analysis.
Contact us at firstname.lastname@example.org and arrange a call to discuss in more detail.
Mark Hughes Foundation Brain Bank
The Mark Hughes Foundation Brain Bank was established to ensure that researchers had access to high quality biospecimens for use in research programs. These samples include Formalin Fixed Paraffin Embedded tissues obtained during diagnostic and debulking surgeries, sequential blood collections and fresh frozen post mortem samples collected through our rapid autopsy program. All samples are annotated with minimum clinical datasets which can be expanded upon at researchers request.
If your research proposal will require the use of biospecimens, either from the established collection or though the implementation of specific collection protocols, please contact the biobank team to discuss the available samples and support services. Due to the generous support of the Mark Hughes Foundation there are large collections of samples that are available free of charge to researchers. For all other collections and services the biobank staff are happy to assist with the preparation of a cost estimate for your proposal budget.
For further information please contact email@example.com